Neuburgh Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $307K | Buy |
11,186
+408
| +4% | +$11.2K | 0.01% | 582 |
|
|
2019
Q2 | $357K | Hold |
10,778
| – | – | 0.01% | 549 |
|
|
2019
Q1 | $378K | Hold |
10,778
| – | – | 0.01% | 523 |
|
|
2018
Q4 | $358K | Hold |
10,778
| – | – | 0.01% | 482 |
|
|
2018
Q3 | $543K | Buy |
10,778
+1,972
| +22% | +$99.4K | 0.02% | 439 |
|
|
2018
Q2 | $527K | Hold |
8,806
| – | – | 0.02% | 411 |
|
|
2018
Q1 | $403K | Buy |
8,806
+374
| +4% | +$17.1K | 0.01% | 466 |
|
|
2017
Q4 | $336K | Buy |
8,432
+1,768
| +27% | +$70.5K | 0.01% | 521 |
|
|
2017
Q3 | $266K | Buy |
6,664
+884
| +15% | +$35.3K | 0.01% | 537 |
|
|
2017
Q2 | $249K | Buy |
5,780
+2,720
| +89% | +$117K | 0.01% | 531 |
|
|
2017
Q1 | $96K | Buy |
3,060
+306
| +11% | +$9.6K | ﹤0.01% | 623 |
|
|
2016
Q4 | $70K | Buy |
+2,754
| New | +$70K | ﹤0.01% | 673 |
|